After agreeing initially, Iran is backing away from its commitment to the nuclear deal that would turn its low-grade uranium into reactor fuel for medical isotopes. But Iran is unable to make the reactor fuel itself, which may be why the U.S. and Europe are willing to give Iran’s leaders some time to contemplate their problem.